Although the gap between low and high value has been established in many areas, insurance design has yet to adapt, according ...

Combining BET inhibitors and PARP inhibitors might help patients resistant to chemotherapy, the study suggests.

Researchers of a Swedish study advise physicians to consult with their patients about these risks and take extra precautions, ...

Clinical characteristics were associated with different survival outcomes in patients treated with immune checkpoint ...

Regulating hemoglobin levels could help reduce inflammation and improve rheumatoid arthritis management. Hemoglobin (Hb) is ...

The extension of the emergency declaration, originally set to expire on March 21, continues to allocate funding to addressing ...

The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...

The PROMPT trials evaluate the influence of electronic health alerts for informing appropriate, evidence-based therapies to patients with cardiovascular conditions.

Patients who did not complete a distress screener were also less likely to receive autologous stem cell transplants.

Toon Van Gorp, MD, PhD, a MIRASOL trial investigator, emphasizes that the final analysis reinforces the efficacy of mirvetuximab soravtansine-gynx (Elahere; AbbVie) in patients with folate receptor ...

The HIV prevention division could be rolled into another department of the HHS as soon as the end of the week.

A study of 200 patients with chronic lymphocytic leukemia (CLL) showed a lower rate of severe and serious adverse events among those treated with zanubrutinib compared with ibrutinib.